Melior Pharmaceuticals Announces Positive Results in Phase 2B Study with Tolimidone for Type 2 Diabetes
Tolimidone treatment significantly reduced HbA1c compared to placebo
• Company makes strategic decision to move tolimidone into NASH development

See more here


Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies Results
Research Findings Accepted for Publication in Journal of Clinical Psychopharmacology  

See more here


VenatoRx Pharmaceuticals Names Lisa Wittmer, Ph.D. Chief Development Officer

See more here


Gina DiGuglielmo Joins Relmada as Vice President and Head of Clinical Operations
Ms. DiGuglielmo consolidates and expands her role from advisor to a full-time position to lead Relmada’s clinical operations 

See more here


Life Sciences PA. reveals awards for its top CEO, top products and deal of the year

See more here


VenatoRx Pharmaceuticals Awarded NIAID R01 Grant to Uncover Determinants of Gram-Negative Permeability
Leveraging a Unique Small Molecule Library, VenatoRx seeks to open challenging bottlenecks for antibacterial drug discovery and successfully introduce new antibacterial agents into the clinic 

See more here


Children’s of Alabama Selects Bainbridge Health to Support its Continued Commitment to Medication Safety and Stewardship
Bainbridge Health is partnering with Children’s of Alabama, ranked among the best pediatric medical centers in the nation by U.S. News and World report, to further bolster its efforts to improve medication safety and stewardship. 

See more here


ENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA(R) (pembrolizumab) for Advanced Solid Tumors

See more here


Group K Diagnostics Relocates to New Laboratory, Manufacturing and Office Space in Philadelphia

See more here